Efficiently targeting neuroblastoma with the combination of anti-ROR1 CAR NK cells and N-803 in vitro and in vivo in NB xenografts

Key Points

• Targeting neuroblastoma effectively improves cell response and viability.
• Combined treatment shows enhanced effects in xenografts and cell cultures.
• Analysis across in vitro and in vivo models supports the treatment strategy.
• This approach highlights the potential for more effective cancer therapies.